.

Sponsored by EuBiologics, co-hosted by the International Vaccine Institute (IVI) and Korea’s CDC (KDCA), the forum consisted of pandemic profiteers, gene therapy peddlers, and global health bureaucrats. Below is a session-by-session breakdown of what they’re planning next:

Speakers: Dr. Dokeun Kim, Director General of the Center for Vaccine Research at the Korea National Institute of Health under KDCA and Dr. Sanjay Singh, CEO of Gennova Biopharmaceuticals

• Set the tone: “mRNA is the future” — not just for pandemics, but for everything(autoimmune disease, cancer, etc.).
• Sanjay Singh heavily promoted the extremely dangerous self-amplifying mRNA (saRNA) replicon platform.

.

.

Speakers:Dr. Martina Ochs, Project Leader of the mRNA Program at the Coalition for Epidemic Preparedness Innovations (CEPI) and Prof. Dan Barouch, William Bosworth Castle Professor of Medicine at Harvard Medical School,

• CEPI’s Martina Ochs revealed plans to use mRNA to “prepare” for future outbreaks — i.e., pre-authorized genetic vaccines waiting for the next declared emergency. Emphasized “the need for speed” when developing mRNA shots.

.

.

• Harvard’s Dan Barouch falsely claimed COVID-19 vaccines “saved 20 million lives in 2021”, then pitched correlates of protection to fine-tune future mRNA updates for respiratory viruses — including potential for routine intranasal or seasonal gene injections.

.

.

Speakers:Dr. Robert Paris, Vice President and Therapeutic Area Head at Moderna, Prof. Minkyung Baek of Seoul National University, and Dr. Sang Hwan Seo, Director at IVI

• AI-designed vaccines — merging artificial intelligence with synthetic biology to design shots in days, not years.

.

.

• Moderna’s Robert Paris pushed expanding mRNA to chronic diseases — another mass market expansion.

.

.

• Mobile mRNA manufacturing (“DeCAFx”) projects presented as “decentralization” — but really a global template for on-demand gene shot production in every region.

.

.

Speakers: Prof. Gerald McInerney of Karolinska Institutet, Dr. Hae-Jin Hu, Research Director at QuadMedicine, and Prof. Hyukjin Lee of Seoul National University

• Self-Amplifying RNA (saRNA) hailed as more efficient.
• Microneedle Array Patch (MAP) promoted as a pain-free, “equity-friendly” vaccine — but it’s a step toward unmonitored home gene therapy, bypassing medical supervision. The Gates Foundation has funded a method to implant permanent quantum dots to verify vaccination status using MAP technology.

.

.

• New lipid nanoparticles presented as ways to penetrate more tissues, more efficiently. What’s not said: easier penetration also means greater biodistribution — including to the brain and reproductive organs.

.